Product Code: GVR-4-68040-382-6
L-Citrulline Market Growth & Trends:
The global L-Citrulline market size is expected to reach USD 2,276.0 million by 2030, at a projected CAGR of 5.0% from 2024 to 2030, according to a new report by Grand View Research, Inc. The expanding utilization of L-citrulline across diverse industries and its rising application in manufacturing active pharmaceutical ingredients (APIs) within the healthcare sector are expected to present abundant growth prospects for the L-citrulline market in the foreseeable future. This growth is fueled by the manifold advantages of L-citrulline, encompassing its incorporation in energy drinks, food products, and beverages, as well as its potential role in early disease detection.
Increasing health consciousness among consumers has led to a greater focus on maintaining a robust immune system and optimal digestive health. People are becoming more proactive about their health, seeking supplements that offer specific benefits, which is a key factor in contributing to the growth of the L-Citrulline market.
L-citrulline is increasingly recognized in food production and beverage applications for its ability to boost exercise performance, alleviate muscle soreness, and enhance recovery. These benefits have made it a coveted ingredient in energy drinks, nutritional supplements, and a variety of health-focused food products. This trend underscores the rising consumer preference for functional foods and beverages that provide added health advantages.
L-Citrulline Market Report Highlights:
- Capsule segment possess a share of 48.49% in 2023 as they are easy to carry and portable, offering a convenient solution for consumers who need to take their supplements while on the move. With the growing health consciousness among people and the increasing demand for effective dietary supplements, the preference for convenient and user-friendly forms such as capsules is on the rise
- The supermarkets and hypermarkets segment is expected to witness a CAGR of 5.0% as these stores frequently develop private label products in partnership with supplement brands. This collaboration enables them to provide high-quality supplements at more affordable prices than national brands
- North America held a market share of 32.99% in 2023. Increasing consumer awareness and a growing preference for nutritional supplements and fortified food products have fueled the demand for L-citrulline in North America. Its significant contributions to overall health, including metabolism and cardiovascular function, have garnered popularity among health-conscious consumers in the region
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Market Definition
- 1.3. Information Procurement
- 1.3.1. Purchased Database
- 1.3.2. GVR's Internal Database
- 1.3.3. Secondary Forms & Third-Party Perspectives
- 1.3.4. Primary Research
- 1.4. Information Analysis
- 1.4.1. Data Analysis Models
- 1.5. Market Formulation & Data Visualization
- 1.6. Data Validation & Publishing
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Form Outlook
- 2.3. Distribution Channel Outlook
- 2.4. Regional Outlook
- 2.5. Competitive Insights
Chapter 3. L-Citrulline Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.2. Industry Value Chain Analysis
- 3.2.1. Sales/Retail Channel Analysis
- 3.2.2. Profit Margin Analysis
- 3.3. Market Dynamics
- 3.3.1. Market Driver Analysis
- 3.3.2. Market Restraint Analysis
- 3.3.3. Industry Challenges
- 3.3.4. Industry Opportunities
- 3.4. Industry Analysis - Porter's
- 3.5. Market Entry Strategies
Chapter 4. L-Citrulline Market: Form Analysis & Estimates
- 4.1. Form Analysis & Market Share, 2023 & 2030
- 4.2. Capsules
- 4.2.1. Market estimates and forecast, 2018 - 2030, (USD Million)
- 4.3. Tablets
- 4.3.1. Market estimates and forecast, 2018 - 2030, (USD Million)
- 4.4. Powders
- 4.4.1. Market estimates and forecast, 2018 - 2030, (USD Million)
- 4.5. Others
- 4.5.1. Market estimates and forecast, 2018 - 2030, (USD Million)
Chapter 5. L-Citrulline Market: Distribution Channel Analysis & Estimates
- 5.1. Form Analysis & Market Share, 2023 & 2030
- 5.2. Supermarkets & Hypermarkets
- 5.2.1. Market estimates and forecast, 2018 - 2030, (USD Million)
- 5.3. Pharmacy & Drug Stores
- 5.3.1. Market estimates and forecast, 2018 - 2030, (USD Million)
- 5.4. Health Stores
- 5.4.1. Market estimates and forecast, 2018 - 2030, (USD Million)
- 5.5. Online
- 5.5.1. Market estimates and forecast, 2018 - 2030, (USD Million)
- 5.6. Others
- 5.6.1. Market estimates and forecast, 2018 - 2030, (USD Million)
Chapter 6. L-Citrulline Market: Regional Estimates & Trend Analysis
- 6.1. Regional Movement Analysis & Market Share, 2023 & 2030
- 6.2. North America
- 6.2.1. Market estimates and forecast, 2018 - 2030, (USD Million)
- 6.2.2. U.S.
- 6.2.2.1. Key country dynamics
- 6.2.2.2. Market estimates and forecast, 2018 - 2030, (USD Million)
- 6.2.3. Canada
- 6.2.3.1. Key country dynamics
- 6.2.3.2. Market estimates and forecast, 2018 - 2030, (USD Million)
- 6.2.4. Mexico
- 6.2.4.1. Key country dynamics
- 6.2.4.2. Market estimates and forecast, 2018 - 2030, (USD Million)
- 6.3. Europe
- 6.3.1.1. Market estimates and forecast, 2018 - 2030, (USD Million)
- 6.3.2. UK
- 6.3.2.1. Key country dynamics
- 6.3.2.2. Market estimates and forecast, 2018 - 2030, (USD Million)
- 6.3.3. Germany
- 6.3.3.1. Key country dynamics
- 6.3.3.2. Market estimates and forecast, 2018 - 2030, (USD Million)
- 6.3.4. France
- 6.3.4.1. Key country dynamics
- 6.3.4.2. Market estimates and forecast, 2018 - 2030, (USD Million)
- 6.3.5. Spain
- 6.3.5.1. Key country dynamics
- 6.3.5.2. Market estimates and forecast, 2018 - 2030, (USD Million)
- 6.3.6. Italy
- 6.3.6.1. Key country dynamics
- 6.3.6.2. Market estimates and forecast, 2018 - 2030, (USD Million)
- 6.4. Asia Pacific
- 6.4.1. Market estimates and forecast, 2018 - 2030, (USD Million)
- 6.4.2. China
- 6.4.2.1. Key country dynamics
- 6.4.2.2. Market estimates and forecast, 2018 - 2030, (USD Million)
- 6.4.3. Japan
- 6.4.3.1. Key country dynamics
- 6.4.3.2. Market estimates and forecast, 2018 - 2030, (USD Million)
- 6.4.4. India
- 6.4.4.1. Key country dynamics
- 6.4.4.2. Market estimates and forecast, 2018 - 2030, (USD Million)
- 6.4.5. Australia & New Zealand
- 6.4.5.1. Key country dynamics
- 6.4.5.2. Market estimates and forecast, 2018 - 2030, (USD Million)
- 6.4.6. South Korea
- 6.4.6.1. Key country dynamics
- 6.4.6.2. Market estimates and forecast, 2018 - 2030, (USD Million)
- 6.5. Central & South America
- 6.5.1.1. Market estimates and forecast, 2018 - 2030, (USD Million)
- 6.5.2. Brazil
- 6.5.2.1. Key country dynamics
- 6.5.2.2. Market estimates and forecast, 2018 - 2030, (USD Million)
- 6.6. Middle East & Africa
- 6.6.1.1. Market estimates and forecast, 2018 - 2030, (USD Million)
- 6.6.2. South Africa
- 6.6.2.1. Key country dynamics
- 6.6.2.2. Market estimates and forecast, 2018 - 2030, (USD Million)
Chapter 7. Competitive Analysis
- 7.1. Recent developments & impact analysis, by key market participants
- 7.2. Company Categorization
- 7.3. Participant's Overview
- 7.4. Financial Performance
- 7.5. Product Benchmarking
- 7.6. Company Market Share Analysis, 2023 (%)
- 7.7. Company Heat Map Analysis
- 7.8. Strategy Mapping
- 7.9. Company Profiles
- 7.10. NOW Foods
- 7.10.1. Company Overview
- 7.10.2. Financial Performance
- 7.10.3. Product Benchmarking
- 7.10.4. Strategic Initiatives
- 7.11. BulkSupplements
- 7.11.1. Company Overview
- 7.11.2. Financial Performance
- 7.11.3. Product Benchmarking
- 7.11.4. Strategic Initiatives
- 7.12. GNC (General Nutrition Centers)
- 7.12.1. Company Overview
- 7.12.2. Financial Performance
- 7.12.3. Product Benchmarking
- 7.12.4. Strategic Initiatives
- 7.13. Primaforce
- 7.13.1. Company Overview
- 7.13.2. Financial Performance
- 7.13.3. Product Benchmarking
- 7.13.4. Strategic Initiatives
- 7.14. Pure Encapsulations
- 7.14.1. Company Overview
- 7.14.2. Financial Performance
- 7.14.3. Product Benchmarking
- 7.14.4. Strategic Initiatives
- 7.15. Jarrow Formulas
- 7.15.1. Company Overview
- 7.15.2. Financial Performance
- 7.15.3. Product Benchmarking
- 7.15.4. Strategic Initiatives
- 7.16. Glanbia plc
- 7.16.1. Company Overview
- 7.16.2. Financial Performance
- 7.16.3. Product Benchmarking
- 7.16.4. Strategic Initiatives
- 7.17. Nutricost
- 7.17.1. Company Overview
- 7.17.2. Financial Performance
- 7.17.3. Product Benchmarking
- 7.17.4. Strategic Initiatives
- 7.18. Doctor's Best
- 7.18.1. Company Overview
- 7.18.2. Financial Performance
- 7.18.3. Product Benchmarking
- 7.18.4. Strategic Initiatives
- 7.19. Life Extension
- 7.19.1. Company Overview
- 7.19.2. Financial Performance
- 7.19.3. Product Benchmarking
- 7.19.4. Strategic Initiatives